The information contained in this website is intended for US healthcare providers only.
UNITHROID is the first FDA-approved levothyroxine sodium treatment for hypothyroidism.1,2 Below are just a few of many reasons why more and more healthcare providers are turning to UNITHROID for their patients with hypothyroidism.
UNITHROID has been consistently manufactured in the same state-of-the-art facility since it was first introduced more than
UNITHROID is manufactured exclusively in New York, which helps ensure consistency and quality of the product.3
UNITHROID contains no ingredient made from a gluten-containing grain (wheat, barley, or rye).3
UNITHROID production adheres to Current Good Manufacturing Practices (CGMP)
The CGMP is an FDA initiative that helps ensure the quality of drug products. The regulations make sure that a product has the ingredients and strength it claims to, and is safe.4
When treating hypothyroidism, it can be important to know that your patients are receiving the exact same medication you prescribed with each and every refill.
In fact, ATA/AACE Guidelines recommend that patients should be maintained on the same levothyroxine preparation. The guidelines also state that patients should have their serum TSH retested after 4 to 8 weeks if they are switched to a different levothyroxine preparation.5
Prescribing UNITHROID by name—and writing dispense as written (DAW)†—provides assurance that patients consistently receive the same levothyroxine preparation with every refill instead of various generic substitutes.
UNITHROID has been manufactured for more than 20 years with no recalls, reformulations, or gaps in availability.3
Because levothyroxine has a narrow therapeutic range, small differences in absorption can result in subclinical or clinical hypothyroidism or hyperthyroidism.6
Because levothyroxine has a narrow therapeutic index, careful dosage titration is necessary to avoid over- or under-treatment.1
When managing hypothyroidism, consistency matters, from taking medicine the same way, every day, to making sure patients always receive the exact treatment you prescribe.
We know that cost is an important consideration when selecting a treatment option for a life-long condition. That’s why we're happy to let you know:
Subject to eligibility. Individual out-of-pocket costs may vary. Not valid for patients covered under Medicare, Medicaid, or other federal or state programs.
Please see full Eligibility Criteria and Terms and Conditions below.
If you would like to receive UNITHROID samples, ask your UNITHROID representative, or email firstname.lastname@example.org.
In the email, please include your name, address, and the sample strengths you are most interested in receiving.
If your patient’s pharmacy does not currently stock their prescribed dosage strength, or you and your patients have questions or are experiencing other issues getting UNITHROID, please email or call us.
UNITHROID is contraindicated in patients with uncorrected adrenal insufficiency.
Warnings and Precautions
Use in Specific Populations
UNITHROID is L-thyroxine (T4) indicated in pediatric and adult patients for:
Limitations of Use:
UNITHROID is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with UNITHROID may induce hyperthyroidism. UNITHROID is not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
To report SUSPECTED ADVERSE REACTIONS, contact Amneal Specialty, a division of Amneal Pharmaceuticals LLC at 1-877-835-5472 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.